179 related articles for article (PubMed ID: 31495406)
1. Add-on parenteral therapy in pulmonary arterial hypertension: The good, the bad, and the ugly.
Schoenberg NC; Farber HW
J Heart Lung Transplant; 2019 Sep; 38(9):1003-1005. PubMed ID: 31495406
[No Abstract] [Full Text] [Related]
2. An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
Hill NS; Farber HW; Preston IR
Am J Respir Crit Care Med; 2020 Mar; 201(6):647-649. PubMed ID: 31904994
[No Abstract] [Full Text] [Related]
3. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.
McLaughlin VV; Palevsky HI
Clin Chest Med; 2013 Dec; 34(4):825-40. PubMed ID: 24267307
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension complicating pulmonary fibrosis: bad and ugly, but good to treat?
Nathan SD
Thorax; 2014 Feb; 69(2):107-8. PubMed ID: 24431094
[No Abstract] [Full Text] [Related]
5. Rebuttal From Dr Frantz.
Frantz RP
Chest; 2020 Apr; 157(4):768-769. PubMed ID: 32252927
[No Abstract] [Full Text] [Related]
6. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward.
Waxman AB
Circulation; 2013 Feb; 127(5):563-5. PubMed ID: 23307828
[No Abstract] [Full Text] [Related]
7. Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension.
Bacha NC; Levy M; Guerin CL; Le Bonniec B; Harroche A; Szezepanski I; Renard JM; Gaussem P; Israel-Biet D; Boulanger CM; Smadja DM
Pediatr Pulmonol; 2019 Jan; 54(1):66-72. PubMed ID: 30485728
[TBL] [Abstract][Full Text] [Related]
8. The good the bad and the ugly.
Corris PA; Sithamparanathan S; Thirugnanasothy L
Thorax; 2014 Sep; 69(9):870-1. PubMed ID: 24760739
[No Abstract] [Full Text] [Related]
9. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension.
Shimizu M; Imanishi J; Takano T; Miwa Y
Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462
[TBL] [Abstract][Full Text] [Related]
10. Understanding the pharmacokinetics of oral treprostinil in patients with pulmonary arterial hypertension.
de Jesus Perez VA
J Cardiovasc Pharmacol; 2013 Jun; 61(6):471-3. PubMed ID: 23575261
[No Abstract] [Full Text] [Related]
11. Impact of Pulmonary Capillary Wedge Pressure on Long-Term Mortality in Patients With Pulmonary Arterial Hypertension Treated With Parenteral Trepostinil.
Patel JK; Rao Y; Strachan P
Heart Lung Circ; 2018 Feb; 27(2):183-189. PubMed ID: 28400191
[TBL] [Abstract][Full Text] [Related]
12. Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.
Airhart S; Verlinden N; Badie N; Raina A; Benza R
J Heart Lung Transplant; 2019 Feb; 38(2):227-230. PubMed ID: 30691597
[No Abstract] [Full Text] [Related]
13. Prostacyclin Therapy for Pulmonary Arterial Hypertension Evolves Again With the Development of an Implantable Delivery System.
Wirth JA; Palevsky HI
Chest; 2017 Dec; 152(6):1100-1102. PubMed ID: 29223256
[No Abstract] [Full Text] [Related]
14. Transition from parenteral to oral treprostinil in pulmonary arterial hypertension.
Chakinala MM; Feldman JP; Rischard F; Mathier M; Broderick M; Leedom N; Laliberte K; White RJ
J Heart Lung Transplant; 2017 Feb; 36(2):193-201. PubMed ID: 27469018
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy in pulmonary arterial hypertension.
Pugh ME; Hemnes AR; Robbins IM
Clin Chest Med; 2013 Dec; 34(4):841-55. PubMed ID: 24267308
[TBL] [Abstract][Full Text] [Related]
16. Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension.
Koo R; Lo J; Bock MJ
Cardiol Young; 2019 Jun; 29(6):849-851. PubMed ID: 31379316
[TBL] [Abstract][Full Text] [Related]
17. Oral treprostinil for the treatment of pulmonary arterial hypertension.
de Lartigue J
Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906
[TBL] [Abstract][Full Text] [Related]
18. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No.
Channick RN; Saggar R
Chest; 2019 Dec; 156(6):1043-1045. PubMed ID: 31812189
[No Abstract] [Full Text] [Related]
19. Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
Tonelli AR; Ahmed MK; Alkukhun L; Cikach F; Aulak K; Dweik RA
Am J Respir Crit Care Med; 2015 Oct; 192(8):1014-6. PubMed ID: 26469842
[No Abstract] [Full Text] [Related]
20. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
Aman J; Hovingh GK
Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
